METHODS OF IDENTIFYING GENETIC RISK FOR AND EVALUATING TREATMENT OF ALZHEIMER'S DISEASE BY DETERMINING CYP46 GENOTYPE

Details for Australian Patent Application No. 2002235924 (hide)

Owner UNIVERSITY OF ZURICH

Inventors PAPASSOTIROPOULOS, Andreas; STREFFER, Johannes, R.; NITSCH, Roger, M.; HOCK, Christoph

Pub. Number AU-A-2002235924

PCT Pub. Number WO2003/046579

Priority 60/331,174 09.11.01 US; 01126773.9 09.11.01 EP

Filing date 1 March 2002

Wipo publication date 10 June 2003

International Classifications

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

21 August 2003 Application Open to Public Inspection

  Published as AU-A-2002235924

29 July 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002235925-Tumour peptide antigen produced from human mdm2 proto-oncogene

2002235923-PRODUCTION OF A SURFACECOATED SOLID OBJECT